Literature DB >> 1336180

Different binding site requirements for binding and activation for the bipartite enhancer factor EF-1A.

G M Bolwig1, J T Bruder, P Hearing.   

Abstract

The human transcription factor EF-1A binds to the purine-rich E1A core enhancer sequence in the adenovirus E1A and E4 and polyomavirus enhancer regions. The consensus binding site for EF-1A resembles that of members of the ets domain protein family. EF-1A activation of transcription requires a dimeric binding site. Analysis of binding sites containing point mutations revealed that EF-1A binding is determined by the core nucleotides of the binding site, while transcriptional activation is determined both by the core and some peripheral nucleotides that do not affect binding. We have purified EF-1A and analyzed its two constituent subunits, EF-1A alpha and EF-1A beta. EF-1A alpha (MW approximately 60kD) makes the primary DNA contacts. EF-1A beta (MW approximately 50 kD) forms a heteromultimeric complex with EF-1A alpha both in solution and on a dimeric binding site. Binding of both EF-1A subunits is necessary, but not sufficient, for transcriptional activation. We present immunochemical and functional evidence that EF-1A alpha is related to the murine ets-related protein GABP alpha and that EF-1A beta is related to the murine protein GABP beta.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336180      PMCID: PMC334571          DOI: 10.1093/nar/20.24.6555

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.

Authors:  B Wasylyk; C Wasylyk; P Flores; A Begue; D Leprince; D Stehelin
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

2.  erg, an ets-related gene, codes for sequence-specific transcriptional activators.

Authors:  E S Reddy; V N Rao
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

3.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

Review 4.  Commitment and activation at pol II promoters: a tail of protein-protein interactions.

Authors:  B Lewin
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

5.  Nuclear factor EF-1A binds to the adenovirus E1A core enhancer element and to other transcriptional control regions.

Authors:  J T Bruder; P Hearing
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  elk, tissue-specific ets-related genes on chromosomes X and 14 near translocation breakpoints.

Authors:  V N Rao; K Huebner; M Isobe; A ar-Rushdi; C M Croce; E S Reddy
Journal:  Science       Date:  1989-04-07       Impact factor: 47.728

7.  Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus.

Authors:  C V Gunther; J A Nye; R S Bryner; B J Graves
Journal:  Genes Dev       Date:  1990-04       Impact factor: 11.361

8.  The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated.

Authors:  A Seth; T S Papas
Journal:  Oncogene       Date:  1990-12       Impact factor: 9.867

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.

Authors:  C Wasylyk; A Gutman; R Nicholson; B Wasylyk
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

View more
  14 in total

1.  The L4 22-kilodalton protein plays a role in packaging of the adenovirus genome.

Authors:  Philomena Ostapchuk; Mary E Anderson; Sharanya Chandrasekhar; Patrick Hearing
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Functional domains of transcription factor hGABP beta1/E4TF1-53 required for nuclear localization and transcription activation.

Authors:  C Sawa; M Goto; F Suzuki; H Watanabe; J Sawada; H Handa
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

3.  Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivation.

Authors:  L M Boccia; D Lillicrap; K Newcombe; C R Mueller
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

4.  A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.

Authors:  N Yokomori; R Kobayashi; R Moore; T Sueyoshi; M Negishi
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

5.  Characterization of a hepatoma mRNA transcribed from a third promoter of a 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-encoding gene and controlled by ets oncogene-related products.

Authors:  V J Dupriez; M I Darville; I V Antoine; A Gegonne; J Ghysdael; G G Rousseau
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation.

Authors:  D J Pereira; N Muzyczka
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression.

Authors:  J T Bruder; I Kovesdi
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Bipartite structure and functional independence of adenovirus type 5 packaging elements.

Authors:  S I Schmid; P Hearing
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter.

Authors:  E Flory; A Hoffmeyer; U Smola; U R Rapp; J T Bruder
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Functional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer I.

Authors:  A D Garcia; P Ostapchuk; P Hearing
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.